US › Healthcare

Armata Pharmaceuticals Inc (ARMP)

US · Healthcare · Biotechnology

$4.10+0.74%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.5M

Revenue YoY

+15.7%

Net profit

$74.1M

EPS

$-0.27

EPS estimate

$-0.48

Net margin

2,953.8%

EPS came in at -0.27 against a street estimate of -0.48 — a beat of 43.7%.

Key statistics

Market cap

$151.3M

Forward P/E

0.0

P/B

2.11

Book value

$-6.22

EPS (TTM)

$-4.89

52-week high

$14.98

52-week low

$2.94

50-day MA

$4.88

200-day MA

$7.44

Beta

1.35

Analyst view

Analysts rate Armata Pharmaceuticals Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $17.50.

Shareholding

Insiders

67.64%

Institutions

13.45%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Armata Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.